Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Gammagard S / D (Immune Globulin Intravenous) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Gammagard S / D side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-27
Patient: 62 year old female
Reactions: Agitation, Personality Change, Dysphagia, Hallucination, Auditory, Cerebellar Syndrome, Facial Pain, Blood Lactic Acid Increased, Chronic Lymphocytic Leukaemia, Hyperproteinaemia, Neoplasm Recurrence, Optic Neuropathy, Insomnia, Toxic Neuropathy, Blood Creatinine Increased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-01-01
End date: 2006-05-01
Cyclophosphamide
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2009-04-01
End date: 2009-04-01
Gammagard S / D
Indication: Hypogammaglobulinaemia
Start date: 2009-02-01
Cyclophosphamide
Administration route: Oral
Start date: 2009-01-06
End date: 2009-01-01
Fludarabine Phosphate
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2009-04-01
End date: 2009-04-01
Fludarabine Phosphate
Administration route: Oral
Start date: 2009-02-25
End date: 2009-02-01
Fludarabine Phosphate
Start date: 2010-04-17
End date: 2010-04-21
Fludarabine Phosphate
Administration route: Oral
Start date: 2009-01-06
End date: 2009-01-01
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2009-01-06
End date: 2009-04-03
Cyclophosphamide
Administration route: Oral
Start date: 2009-02-25
End date: 2009-02-01
Fludarabine Phosphate
Start date: 2005-11-01
End date: 2006-05-01
Other drugs received by patient: Vincristine; Doxorubicin HCL; Antilymphocyte Serum; Cyclosporine; Octagam; Busulfan; Prednisolone
|